Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001209191-23-009875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-02-15 | 2023-02-14 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $83.49 | -30.8K | 65.3K | -32% | -$2.57M |
| DI | 2023-02-15 | 2023-02-14 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.50 | +30.8K | 82.7K | +59% | +$1.40M |
| DI | 2023-02-15 | 2023-02-13 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | G - Gift | $0.00 | +98.2K | 98.2K | New | $0 |
| D | 2023-02-15 | 2023-02-13 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | G - Gift | $0.00 | -98.2K | 0 | -100% | $0 |
| DI | 2023-02-15 | 2023-02-14 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -30.8K | 61.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-14 | S | D | 13,444 | $83.76 | 51,879 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $83.67 to $83.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Class A Common Stock | 2023-02-14 | M | A | 30,780 | $45.50 | 82,659 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | |
| 3 | Common | Class A Common Stock | 2023-02-14 | S | D | 17,336 | $83.28 | 65,323 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $82.67 to $83.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-13 | G | A | 98,200 | $0.00 | 98,200 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | $71.07 · — to 2032-12-15 | 98,200 Class A Common Stock | (F5) This option was granted for a total of 98,200 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-13 | G | D | 98,200 | $0.00 | 0 | D By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | $71.07 · — to 2032-12-15 | 98,200 Class A Common Stock | (F5) This option was granted for a total of 98,200 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-14 | M | D | 30,780 | $0.00 | 61,559 | I | $45.50 · — to 2023-12-15 | 30,780 Class A Common Stock | (F6) This performance-based stock option award was granted for a total of 97,199 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 92,339 shares. |